LSM3_HUMAN - dbPTM
LSM3_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID LSM3_HUMAN
UniProt AC P62310
Protein Name U6 snRNA-associated Sm-like protein LSm3
Gene Name LSM3
Organism Homo sapiens (Human).
Sequence Length 102
Subcellular Localization Nucleus .
Protein Description Binds specifically to the 3'-terminal U-tract of U6 snRNA..
Protein Sequence MADDVDQQQTTNTVEEPLDLIRLSLDERIYVKMRNDRELRGRLHAYDQHLNMILGDVEETVTTIEIDEETYEEIYKSTKRNIPMLFVRGDGVVLVAPPLRVG
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MADDVDQQQ
------CCCCCCCHH
23.0122814378
10PhosphorylationDDVDQQQTTNTVEEP
CCCCCHHHCCCCCCC
20.0619664995
11PhosphorylationDVDQQQTTNTVEEPL
CCCCHHHCCCCCCCH
25.2630377224
13PhosphorylationDQQQTTNTVEEPLDL
CCHHHCCCCCCCHHH
27.4830377224
24PhosphorylationPLDLIRLSLDERIYV
CHHHHHHCCCCCEEE
24.7521815630
28MethylationIRLSLDERIYVKMRN
HHHCCCCCEEEEECC
25.79115482369
32UbiquitinationLDERIYVKMRNDREL
CCCCEEEEECCCHHH
18.38-
71PhosphorylationIEIDEETYEEIYKST
EEECHHHHHHHHHHC
18.16-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of LSM3_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of LSM3_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of LSM3_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
RUXE_HUMANSNRPEphysical
15231747
SMD3_HUMANSNRPD3physical
15231747
LSM7_HUMANLSM7physical
15231747
XRN2_HUMANXRN2physical
15231747
LSM10_HUMANLSM10physical
15231747
LSM2_HUMANLSM2physical
16189514
LSM10_HUMANLSM10physical
16189514
GDF9_HUMANGDF9physical
16169070
EF1A1_HUMANEEF1A1physical
16169070
UT14A_HUMANUTP14Aphysical
16169070
LSM2_HUMANLSM2physical
16169070
LSM6_HUMANLSM6physical
22939629
LSM7_HUMANLSM7physical
22939629
LSM4_HUMANLSM4physical
22939629
SMD1_HUMANSNRPD1physical
22365833
SMD3_HUMANSNRPD3physical
22365833
RUXG_HUMANSNRPGphysical
22365833
SF3B2_HUMANSF3B2physical
22365833
YBOX1_HUMANYBX1physical
22365833
LSM2_HUMANLSM2physical
22365833
LSM7_HUMANLSM7physical
22365833
LSM8_HUMANLSM8physical
22365833
WDR83_HUMANWDR83physical
22365833
THOC5_HUMANTHOC5physical
22365833
MEP50_HUMANWDR77physical
22365833
ICLN_HUMANCLNS1Aphysical
22365833
LSM10_HUMANLSM10physical
19060904
LSM8_HUMANLSM8physical
21988832
LSM2_HUMANLSM2physical
15231747
LSM8_HUMANLSM8physical
15231747
XPC_HUMANXPCphysical
15231747
CEP95_HUMANCEP95physical
15231747
LSM1_HUMANLSM1physical
15231747
LSM5_HUMANLSM5physical
15231747
LSM6_HUMANLSM6physical
15231747
LSM2_HUMANLSM2physical
25416956
LSM1_HUMANLSM1physical
26344197
LSM6_HUMANLSM6physical
26344197
LSM7_HUMANLSM7physical
26344197
LSMD1_HUMANNAA38physical
26344197
LSM2_HUMANLSM2physical
21516116

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of LSM3_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY.

TOP